Order Article Reprints

Tsai K-Y, Wei P-L, Lee C-C, Makondi PT, Chen H-A, Chang Y-Y, Liu D-Z, Huang C-Y, Chang Y-J. 2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy. Biomedicines. 2023; 11(7):1798. https://doi.org/10.3390/biomedicines11071798

Tsai, Kuei-Yen, Po-Li Wei, Cheng-Chin Lee, Precious Takondwa Makondi, Hsin-An Chen, Yao-Yuan Chang, Der-Zen Liu, Chien-Yu Huang, and Yu-Jia Chang. 2023. "2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy" Biomedicines 11, no. 7: 1798. https://doi.org/10.3390/biomedicines11071798

Tsai, K.-Y., Wei, P.-L., Lee, C.-C., Makondi, P. T., Chen, H.-A., Chang, Y.-Y., Liu, D.-Z., Huang, C.-Y., & Chang, Y.-J. (2023). 2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy. Biomedicines, 11(7), 1798. https://doi.org/10.3390/biomedicines11071798